Literature DB >> 28460106

Dabigatran Compared With Rivaroxaban vs Warfarin-Reply.

Anna L Parks1, Rita F Redberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28460106     DOI： 10.1001/jamainternmed.2017.0571

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  3 in total

1.  Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism.

Authors:  Pamela L Lutsey; Neil A Zakai; Richard F MacLehose; Faye L Norby; Rob F Walker; Nicholas S Roetker; Terrence J Adam; Alvaro Alonso
Journal:  Br J Haematol       Date:  2019-03-28       Impact factor: 6.998

2.  All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism.

Authors:  Nicholas S Roetker; Pamela L Lutsey; Neil A Zakai; Alvaro Alonso; Terrence J Adam; Richard F MacLehose
Journal:  Thromb Haemost       Date:  2018-08-13       Impact factor: 5.249

3.  Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients.

Authors:  Pamela L Lutsey; Faye L Norby; Neil A Zakai; Richard F MacLehose; Lin Y Chen; Surbhi Shah; Yvonne H Datta; Alvaro Alonso
Journal:  Curr Med Res Opin       Date:  2018-12-03       Impact factor: 2.580
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.